Cotinga Pharmaceuticals Inc.Company Review & Valuation

COTQF
OTC Markets
Latest Price
0.02USD

About Cotinga Pharmaceuticals Inc.

Cotinga Pharmaceuticals Inc., a biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, a clinical stage oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small moleculShow more e compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. was founded in 1999 and is based in Boston, Massachusetts. Show less

Industry
Biotechnology
HQ Location
Boston, Massachusetts

Stock Price

Price data not available for Cotinga Pharmaceuticals Inc..

Performance

Please login or create a free account to view the contents of this section.

Financial Reports

Please login or create a free account to view the contents of this section.

Similar Companies

back to top